Komori
C'Bon Cosmetics (4926) · InitiativeAdvanced

Performance-Linked Compensation and Sharing Interests with Shareholders Through Executive Shareholdings

First written in FY2017. 6 of 9 entries say "Advanced", first in FY2018. Latest entry: FY2026.

9entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018AdvancedFY2021 – FY2023-Q2OtherFY2023AdvancedFY2025 – FY20262017: 120172018: 120182019: 020192020: 120202021: 120212022: 220222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Performance-based executive and employee compensation schemeA theme 405 companies write about · 0 as a headwind · 397 as a tailwind

The whole theme swung hardest in 2024: 13 of 118 companies on the "Worse" side.

65 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 191 companies compared. The sentences above are computed from all 191.Comparing 200 of the theme's 418 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Performance-linked compensation for the fiscal year was calculated at ¥2.584 million, equivalent to 1.0% of consolidated operating profit for the fiscal year before recording performance-linked compensation, in accordance with the Company's rules. Of this amount, the ¥1.988 million payable to executive directors, excluding outside directors, is included in the total amount by type of compensation and other benefits stated above.」

    For performance-linked compensation subject to achieving the budgets for net sales and operating profit, an amount equivalent to 1.0%, or ¥2.584 million, was calculated, and ¥1.988 million attributable to directors was recorded.
  2. FY2025AdvancedAnnual report

    「2022 stock options Before vesting (shares) At the end of the previous consolidated fiscal year 19,000 Vested 19,000 Unvested balance — After vesting Vested 19,000 Exercised — Unexercised balance 19,000」

    Vesting was completed for the 19,000 shares underlying the 2022 stock options granted to executive directors and other eligible persons.
  3. FY2023The old stock options expired, while the new plan's unvested balance remains outstanding.Annual report

    「The 2013 stock options included 24,400 expired shares, while 19,000 shares granted under the 2022 stock options remain unvested. The exercise period is from 30 July 2024 to 29 July 2026.」

    While 24,400 shares under the old stock options expired, 19,000 shares granted in 2022 remain outstanding before vesting.
  4. FY2023-Q2AdvancedAnnual report

    「Third Series of Stock Acquisition Rights Date of resolution 29 June 2022 (Annual General Meeting of Shareholders) 21 July 2022 (Board of Directors) Categories and number of persons eligible for grants (people) Directors 3 Employees 2 Number of stock acquisition rights (rights) 190 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 19,000 Exercise period of the stock acquisition rights From 30 July 2024 to 29 July 2026」

    A resolution was passed to grant the Third Series of Stock Acquisition Rights, covering 19,000 common shares, to 3 directors and 2 employees, with an exercise period from 30 July 2024 to 29 July 2026.
  5. FY2022AdvancedAnnual report

    「Performance-linked compensation and other compensation are determined by allocating, using coefficients by position, an amount equivalent to 1.0% of consolidated operating profit, provided that consolidated net sales and consolidated operating profit achieve the initial budget for the fiscal year, in order to increase awareness of improving performance in each fiscal year.」

    The director and executive compensation policy was revised, formalizing performance-linked compensation that allocates 1.0% of operating profit provided that the budgets for consolidated net sales and consolidated operating profit are achieved. The granting of stock acquisition rights and the acquisition of shares through the directors' shareholding association were also disclosed.
  6. FY2021AdvancedAnnual report

    「Performance-linked compensation and other compensation are determined by allocating, using coefficients by position, the amounts calculated under a predetermined compensation table based on annual consolidated net sales and the consolidated ordinary profit margin, excluding performance-linked compensation, in order to increase awareness of improving performance in each fiscal year.」

    The Board of Directors approved the policy for determining director and executive compensation and formalized a performance-linked compensation system based on annual consolidated net sales, the consolidated ordinary profit margin and coefficients by position. No payment was made for the period.
  7. FY2020No performance-linked compensation paidAnnual report

    「No payment will be made if net sales are below ¥12,500 million or if the ordinary profit margin on net sales is below 4.0%.」

    Net sales for the period were ¥10,927.962 million, and the ordinary profit margin on net sales was negative, so no performance-linked compensation was paid under the compensation table.
  8. FY2018AdvancedAnnual report

    「At a meeting of the Board of Directors held on 14 June 2018, a resolution was passed to make part of director and executive compensation performance-linked, based on the following calculation method.」

    The introduction of performance-linked compensation was specified in detail, including a formula based on net sales and the ordinary profit margin on net sales, a maximum aggregate payment of ¥54 million, and coefficients by position.
  9. FY2017First statedAnnual report

    「To increase motivation for the Company's sustainable growth and enhancement of corporate value over the medium to long term, we established a new director and executive compensation system, which will be implemented upon the conclusion of the Annual General Meeting of Shareholders held on 22 June 2017. It will consist of fixed compensation and performance-linked compensation. The maximum aggregate amount payable is ¥54 million, and the aggregate amount payable will be determined based on a calculation method linked to net sales and ordinary profit.」

    As a new director and executive compensation system from the fiscal year ending March 2018 onward, fixed compensation and performance-linked compensation were introduced and linked to net sales and ordinary profit. The Company also disclosed its ownership of its own shares through contributions to the directors' shareholding association.
Moved together

"Expansion of product lines, including natural and anti-aging care" moved the same way as this thread, in the same document, in 6 of its 9 moves.

666544★123456
  1. ★This thread
  2. 1Expansion of product lines, including natural and anti-aging care6×
  3. 2New Customer Acquisition Through Online Outreach and Mail-Order Sales6×
  4. 3Product Development and Capital Investment Funded by Retained Earnings6×
  5. 4Research and Development Center and Open Innovation5×
  6. 5Strengthening the Brand4×
  7. 6Improvement in net sales, ordinary profit, and ordinary profit margin4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
C'Bon Cosmetics's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Performance-Linked Compensation and Sharing Interests with Shareholders Through Executive Shareholdings | C'BON COSMETICS Co.,Ltd. (4926) | Komori